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LIDOCAINE INDUCES ROCK-DEPENDENT MEMBRANE BLEBBING AND
CELL DEATH IN RABBIT ARTICULAR CHONDROCYTE
T. Maeda y,z, S. Imai y, F. Toyoda z, H. Tanigawa y,z, K. Kumagai y,z,
H. Matsuura z, Y. Matsusue y. yDept. of Orthopedic Surgery, Shiga Univ. of
Med. Sci., Otsu, Shiga, Japan; zDept. of Physiology, Shiga Univ. of Med. Sci.,
Otsu, Shiga, Japan
Purpose: Local anesthetics are administered intraarticularly for pain
control in orthopedic clinics and surgeries. Although previous studies
have shown that local anesthetics can be toxic to chondrocytes, the
underlying mechanism remains unclear. The present study was
undertaken to investigate the cellular mechanisms associated with
lidocaine-induced toxicity to articular chondrocytes.
Methods: Isolated rabbit articular chondrocytes were exposed for 30
minutes to lidocaine at concentrations of 1, 3, 10 and 30 mM (360
mosmol$L-1, pH 6.8, 7.4 and 8.7) at 36 C. To evaluate the lidocaine-
induced blebbing, morphological changes of chondrocytes were
monitored using time-lapse microscopy and then the percentage of
blebbing cells was evaluated every minute. The levels of guanosine
triphosphate (GTP)-bound RhoA and caspase-3 were determined using
a RhoA G-LISA assay and a Caspase-Glo 3/7 assay. The viability of
chondrocytes treated with 30 mM lidocaine for an hour was deter-
mined using a LIVE/DEAD® assay kit. To evaluate the percentage of
living cells, the number of living cells (green) and dead cells (red) of
each image were counted by an ImageJ software.
Results: Treatment of chondrocytes with lidocaine caused spherical
protrusions on the cell surface (so called ‘membrane blebbing’) in a
time- and concentration-dependent manner. After 30-min exposure,
lidocaine (pH 7.4) at the concentrations of 1, 3, 10 and 30 mM induced
membrane blebbing in 9.6±1.1%, 35.5±11.6%, 84.1±2.2% and 100±0% of
chondrocytes, respectively, compared with the controls (1.2±2.1%)
(mean±s.d., n¼3). These effects of lidocaine could be ﬁtted by the Hill
equation giving an EC50 of 4.13 mM, which is lower than clinical use
concentrations. When lidocaine was applied under alkaline (pH8.7) or
acidic (pH 6.8) condition, the EC50s were shifted to 1.37 or 11.72 mM,
respectively, as is expected for the pH-dependent change in the con-
centration of non-ionized lidocaine. ROCK (Rho-kinase) inhibitors Y-
27632 (10 mM) and fasudil (100 mM) completely inhibited the lidocaine-
induced membrane blebbing, suggesting that ROCK activation is
required for the blebbing. Although the apoptotic blebbing is typically
caused by the caspase-3-induced cleavage of ROCK-I, the caspase-3
level was unchanged by 20-min treatment of chondrocytes with 10 mM
lidocaine. Furthermore, although it was reported that apoptotic bleb-
bing was abrogated by z-VAD-fmk, a caspase inhibitor, this drug did not
prevent the lidocaine-induced blebbing. These results suggest that
lidocaine-induced membrane blebbing is independent of caspase-3
activity. The GTP-bound RhoA level was signiﬁcantly increased
(3.01±0.76 folds, P < 0.0001) by 20-min treatment of chondrocytes with
10 mM lidocaine. However, Rho inhibitor-1 rather enhanced the
membrane blebbing, suggesting that the lidocaine-induced membrane
blebbing might be at least partially mediated through the pathway
other than canonical Rho/ROCK signaling. Chondrocyte viability was
signiﬁcantly decreased to 17.6±5.7% after 1-h exposure to 30 mM
lidocaine, compared with the control viability of 94.8±2.4% (P <
0.0001). Pretreatment with Y-27632 or fasudil for 1-hour attenuated
the lidocaine induced-cytotoxicity (49.4±12.5% and 47.2±9.1% viability
respectively, P < 0.0001), demonstrating that the lidocaine-induced
hyperactivation of ROCK leaded to chondrotoxicity.
Conclusions: These ﬁndings show that lidocaine induces a cytotoxic
effect on chondrocytes through the mechanism involving membrane
bleb formation and ROCK activation and that caution should be taken
when administering lidocaine intraarticularly.
187
INTERLEUKIN-1BETA IS ESSENTIAL FOR BLOOD-INDUCED
CARTILAGE DAMAGE IN VITRO
L.F. van Vulpen, K. Coeleveld, R.E. Schutgens, E.C. Alsema,
G. Roosendaal, S.C. Mastbergen, F.P. Lafeber. UMC Utrecht, Utrecht,
Netherlands
Purpose: Exposure of joint cartilage to blood can occur after joint
trauma, during or after major joint surgery, or due to hemophilia. This
ultimately leads to joint damage, having both the inﬂammatory char-
acteristics of rheumatoid arthritis and the degenerative characteristicsof osteoarthritis. We previously reported that blocking interleukin(IL)-
1b with a recombinant monoclonal antibody (IL-1bmAb) protects car-
tilage from the damaging effects of blood exposure in a dose-dependent
way (Abstract 155; 2014 World Congress on Osteoarthritis). To further
unravel the role of IL-1b in blood-induced cartilage damage, we
investigated whether blocking IL-1 with a receptor antagonist (IL-1RA)
is also able to prevent blood-induced cartilage damage in vitro, and
whether blocking IL-1b with either IL-1RA or IL-1bmAb after onset of a
bleed is still beneﬁcial.
Methods: Healthy human cartilage explants were cultured for 4 days in
presence/absence of 50% whole blood. IL-1RA was added in a broad
concentration range (10-1000 ng/mL) during blood exposure (n¼7).
Furthermore, IL-1bmAb (100 ng/mL) or IL-1RA (1000 ng/mL) was
administered directly or after a delay of several hours up to 2 days
(n¼7). Proteoglycan turnover was determined after a recovery period of
12 days.
Moreover, in 4-day whole blood cultures (n¼6) the effects of IL-1bmAb
(100 ng/mL) and IL-1RA (1000 ng/mL) on the levels of IL-1b, IL-6, and
TNF-a were determined.
Results: Exposure of cartilage to blood severely impacted proteoglycan
turnover (PG synthesis -76%; p¼0.018 see ﬁgure A; PG release þ125%;
p¼0.018; PG content -18%; p¼0.028; all compared to control). Addition
of IL-1RA resulted in a clear dose-dependent improvement in proteo-
glycan turnover (see ﬁgure A for proteoglycan synthesis). For PG release
and PG content, the highest concentration led to normalisation as
compared to control (PG release þ33% of control (p¼0.063); PG content
þ2% of control (p¼0.866)). The protective effect of IL-1bmAb or IL-1RA
was most pronounced when administered within 8 hours after the
bleed (see ﬁgure B for proteoglycan synthesis upon IL-1RA addition).
Blocking IL-1b reduced IL-6 (21 347 pg/mL in whole blood culture
versus 27 pg/mL and 289 pg/mL after addition of IL-1RA and IL-1bmAb
(both p¼0.028)) and IL-1b (74 pg/mL in whole blood culture versus
undetectable after addition of IL-1RA, p¼0.028) levels in whole blood
cultures, but did not affect the levels of TNF-a (35 pg/mL inwhole blood
culture versus 37 pg/mL after addition of IL-1RA or IL-1bmAb (both
p¼0.753)).
Conclusions: This study demonstrates that IL-1b is a critical factor in
the development of blood-induced cartilage damage in vitro. Blocking it
with either a monoclonal antibody or receptor antagonist protects
cartilage from the damaging effects of blood exposure in a dose- and
time-dependent way. Early administration after blood-exposure is most
beneﬁcial. This key role of IL-1b results at least partly from regulating
the production of other pro-inﬂammatory cytokines, including IL-1b
itself and IL-6. As therapeutic agents opposing the activity of IL-1b are
readily available, further research is warranted to investigate its in vivo
capacity in prevention and treatment of joint damage upon joint
bleeding.
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THE ROLE OF SODIUM HYDROGEN EXCHANGER REGULATORY
FACTOR 1 IN OSTEOARTHRITIS
R. White, M.C. Blair, F.R. Saunders, R.M. Aspden. Univ. of Aberdeen,
Aberdeen, United Kingdom
Purpose: In a pilot study, selected gene expression in tissue samples
from patients with OA and osteoporosis (OP) were compared. The gene,
SLC9A3R1 which encodes for a member of the sodium/hydrogen reg-
ulatory factor protein family (NHERF1) was found to be differentially
expressed in osteoblasts. NHERF1 plays a role in tumour suppression,
via PTEN, and intracellular pH (pHi) regulation by acting on the sodium/
hydrogen exchanger (NHE). We are investigating whether a decrease in
NHERF1 causes a change in the pHi of chondrocytes and leads to
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A135chondrocyte proliferation. The aim of the project is to test the
hypothesis that dysregulated expression of NHERF1 is a key part of the
abnormal behaviour of articular chondrocytes.
Methods: Full depth cartilage explants or shavings were removed from
osteoarthritic femoral heads or knee joints, and from healthy controls
(amputees or osteoporotic femoral heads). Explants from 17 patients (4
OA and 4 non-OA femoral heads, 4 OA knees and 5 amputees) were
decalciﬁed and ﬁxed in formalin for parafﬁn embedding and sectioning,
whilst shavings were placed in Dulbecco’s Modiﬁed Eagles Medium
(DMEM) and washed prior to enzymatic chondrocyte isolation. Sections
were deparafﬁnised and either stained with Fast-Green-FCF and
Safranin ‘O’, or treated with Target Retrieval Solution and hyaluronidase
prior to incubationwith glycine, blocking with non-immune serum and
overnight incubation with either rabbit anti-human NHE3 (pAb, C-20),
mouse anti-human NHERF1 (mAb, IgG2b), or goat anti-human PTEN
(pAb, N19) diluted in Dako Antibody Diluent (1:50: PTEN 1:100). Bound
NHE3, NHERF1 or PTEN antibodies were detected with goat anti-rabbit
(488 nm), goat anti-mouse (555 nm) or donkey anti-goat (488 nm)
secondary antibodies (1:100, PTEN 1:200) respectively. Sections were
mounted with Prolong Gold anti-fade mounting media containing DAPI
and visualized with a Zeiss Imager M2 ﬂuorescent or LSM 700 Zeiss
Imager M2 confocal laser scanning microscope (CLSM). Cell counts and
co-localisation were analysed using Image J software. Isolated articular
chondrocytes (n¼3) were incubated with BCECF-AM (5 mM, 15 mins, 37
oC), washed in DMEM without phenol red, aliquoted ( 14 x 104) and
placed in a sterile Ibidi m-Slide I (0.4) Flow Chamber (Thistle Scientiﬁc,
UK) for 20-30 min (37 oC) to attach. They were washed into the
appropriate saline,After saline washing, and BCECF was then alternately
excited at 488 nm and 458 nm, and emission collected at >505 nm
using a CLSM (Zeiss LSM 710) from individual cells. The background
from each wavelength was subtracted and the 488:458 nm ratio (R)
converted to pHi using a calibration curve constructed by per-
meabilizing the chondrocytes to Hþ in high-potassium (Kþ) solutions
of different pH containing nigericin (2 mM).
Results:NHE3, NHERF1 and PTENwere expressed in all zones of OA and
non-OA articular cartilage. Image J analysis showed that NHERF1 co-
localised with both proteins in the cytoplasm and perinuclear region,
but little was found near the cell membrane. It was also expressed in the
nucleus in 50% of chondrocytes in OA and non-OA samples. The median
diameter of the nuclei of OA chondrocytes was also found to be sig-
niﬁcantly larger (7.47 mm) than in non-OA chondrocytes (6.78 mm,
P¼0.001???). The pHi of normal, healthy chondrocytes was 6.9 þ 0.2
(n¼3) but OA chondrocytes appeared to bemore acidic. The pHi of these
chondrocytes was too low to be recorded successfully and reliably using
BCECF (pKa 6.98) which is used for measuring near neutral pH, so this
necessitated exploring the use of another ﬂuorescein derivative, DCFDA
(pKa 4.8) for pH measurements from pH 4-5
Conclusions: This is the ﬁrst study to identify NHE3, NHERF1 and PTEN
expression and co-localisation in human articular cartilage, and to
measure pHi in single isolated chondrocytes using confocal microscopy
and the ﬂuorescent dyes, BCECF-AM and DCFDA. NHERF1 was expected
at the cell membrane but, surprisingly, location was predominantly
cytoplasmic. Detection of NHERF1 expression and function in articular
cartilage may open new approaches for OA therapy in the future.
189
ANALYSIS OF CARTILAGE BIOMARKERS OF AGING AND TURNOVER IN
THE OSTEOARTHROPATHY OF ALKAPTONURIA
A.M. Taylor y, M.-F. Hsueh z, L.R. Ranganath x, J.A. Gallagher x,
J.B. Catterall z, V.B. Kraus z. y Lancaster Univ., Lancaster, United Kingdom;
zDuke Univ., Durham, NC, USA; xUniv. of Liverpool, Liverpool, United
Kingdom
Purpose: Alkaptonuria (AKU) is a rare autosomal recessive disease that
results from a single enzyme deﬁciency in the tyrosine metabolic
pathway. As a result, homogentisic acid (HGA), a metabolite of tyrosine,
cannot be broken down; despite some urinary excretion, this results in
systemic increases in HGA concentrations. Over time, HGA undergoes
polymerization, termed ochronosis, and deposits as a polymer in col-
lagenous tissues. Typically this occurs in joint cartilages and leads to an
early onset, rapidly progressing osteoarthropathy. The literature sug-
gests that all AKU patients will develop osteoarthropathy, and many
will have multiple joint involvement. Little is currently known about
tissue turnover in cartilage affected by ochronosis and the impact of this
turnover on disease initiation and progression. We investigated theturnover of AKU cartilage using biomarkers of turnover and aging and
compared these to both OA and non-arthritic control cartilage tissues.
We hypothesized that novel age-related biomarkers would provide
insights into cartilage turnover in the context of AKU versus OA
cartilage.
Methods: Samples of hip and knee cartilage were obtained with
informed patient consent at the time of joint arthroplasty surgery for
arthropathy due to alkaptonuria (n¼6) and osteoarthritis (OA, n¼12).
Non-arthritic cartilages (n¼6) were obtained as waste tissues after
trauma surgery. We measured cartilage concentrations (normalized to
dry weight) of several biomarkers including glycosaminoglycan (GAG),
total cartilage oligomeric matrix protein (COMP) and two age-related
biomarkers, deamidated COMP (dCOMP) and aspartate ratio (Asp ratio
representing the proportion of racemized to total aspartate). Using the
nonparametric Mann-Whitney U test for unpaired data, biomarker
results from alkaptonuria samples were compared to results from OA
and non-OA normal samples.
Results: The cartilage samples used for this study represent almost 10%
of the known alkaptonuric population in the UK (knees n¼2, mean age
59.5 years and hips n¼4, mean age 61 years). Compared to both Non-OA
(knee n¼1, mean age 36 years and hip n¼5, mean age 63.4 years) and
OA (knee n¼5, mean age 68.6 years and hip n¼7, mean age 80.5 years)
samples, the mean amount of extractable protein from AKU cartilage
samples was signiﬁcantly greater (p¼0.002 and 0.035 respectively).
However, normalized to total protein, the mean amount of extractable
GAG (p<0.002) and total COMP (p<0.002) were signiﬁcantly lower in
AKU cartilage samples compared to both Non-OA and OA samples. The
age-related biomarkers, mean extractable dCOMP (expressed as a pro-
portion of total COMP) and mean Asp ratio, were both signiﬁcantly
higher in AKU cartilage samples compared to OA samples (p¼0.04 and
p¼0.004, respectively) but not relative to Non-OA cartilage.
Conclusions: To our knowledge these novel data represent the ﬁrst
examination of cartilage matrix components from patients with AKU,
compared with OA and non-arthritic normal controls. These data
demonstrate a signiﬁcantly reduced amount of extractable GAG and
COMP suggestive of an impaired anabolic response. Further support for
lack of appropriate repair response in AKU cartilages was provided by
the results for the age-related biomarkers; both age-related biomarkers
were enriched in AKU relative to OA cartilages suggesting lack of an
anabolic response in degenerating cartilage in AKU. These data suggest
that individuals with AKU may beneﬁt from growth factor and other
anabolic treatments as there appears to be a lack of an anabolic
response to the cartilage degeneration associated with the pathological
ochronotic pigmentation process.
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ELEVATED EXPRESSION OF PERIOSTIN IN HUMAN OSTEOARTHRITIS
CARTILAGE AND ITS POTENTIAL ROLE IN MATRIX DEGRADATION
VIA MMP-13
M. Attur y, Q. Yang y, K. Shimada z, Y. Tachida z, H. Nagase z,
P. Mignatti y, L. Statman y, G. Palmer y,x, T. Kirsch 4, F. Beier ¶,
S.B. Abramson y. yDiv. of Rheumatology, Dept. of Med., New York Univ.
Sch. of Med. and NYU Langone Med. Ctr., New York, NY, USA; z Frontier
Res. Lab., Daiichi Sankyo Co., Ltd., Tokyo, Japan; xDept. of Orthopaedics
and Rehabilitation, Univ. of Florida, Gainesville, FL, USA; kDept. of
Orthopaedic Surgery, New York Univ. Sch. of Med. and Hosp. for Joint
Diseases, New York, NY, USA; ¶Dept. of Physiology and Pharmacology,
Schulich Sch. of Med. and Dentistry, The Univ. of Western Ontario,
London, ON, Canada
Purpose: The synovium, bone, and cartilage are each involved in
pathologic processes that lead to progressive joint degeneration. In
concert with cartilage degeneration, the subchondral plate in knee
joints affected by OA has been shown to have increased bone volume
fraction and trabecular thickness, but reduced tissue mineral density,
consistent with OA being associated with abnormalities in bone turn-
over. We have identiﬁed, using Affymetrix microarray screening and
conﬁrmatory QPCR, that periostin - an osteoblast stimulatory factor
encoded by the gene Postn - is signiﬁcantly overexpressed by chon-
drocytes and subchondral bone in OA.We have also found that periostin
mRNA expression in cartilage is increased in both rat meniscectomy
(MM) and anterior crucial ligament (ACL) surgical models of OA. This
study investigates its expression in rodent models of OA and regulation
of chondrocyte metabolism.
